Footsie sheds value as slow rate of US industrial production raises concern

million, down from ��204m in the same period a year ago. Drugmakers were weak as well, led by GlaxoSmithKline which shed 2.5 per cent after cautious comments from Morgan Stanley. "It would look to take profits in its less favoured stocks, such as GSK,"...